Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 5 results out of 5

Company profileUTC Therapeutics

Access the most comprehensive report about UTC Therapeutics available on the market

Buy Now

Data Insights

CD70 CAR-T is under clinical development by UTC Therapeutics and currently in Phase II for Marginal Zone B-cell Lymphoma. According...

Data Insights

CD70 CAR-T is under clinical development by UTC Therapeutics and currently in Phase II for Anaplastic Large Cell Lymphoma (ALCL)....

Data Insights

Anti-CDH17 CAR-T Cells is under clinical development by UTC Therapeutics and currently in Phase I for Pancreatic Cancer. According to...

Data Insights

Anti-CDH17 CAR-T Cells is under clinical development by UTC Therapeutics and currently in Phase I for Colorectal Cancer. According to...

Data Insights

CD19-CAR-T is under clinical development by UTC Therapeutics and currently in Phase I for Lymphoma. According to GlobalData, Phase I...